{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:31:20Z","timestamp":1782487880084,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11739-023-03267-y","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T16:02:29Z","timestamp":1681747349000},"page":"1087-1093","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pulmonary hypertension in systemic sclerosis with usual interstitial pneumonia"],"prefix":"10.1007","volume":"18","author":[{"given":"Roberto G.","family":"Carbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaf","family":"Monselise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Barisione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Paredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5393-0071","authenticated-orcid":false,"given":"Francesco","family":"Puppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"3267_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00296-020-04720-3","volume":"41","author":"J Ciaffi","year":"2021","unstructured":"Ciaffi J, Morabito MF, Ruscitti P et al (2021) Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data. Rheumatol International 41:129\u2013137. https:\/\/doi.org\/10.1007\/s00296-020-04720-3","journal-title":"Rheumatol International"},{"key":"3267_CR2","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s10067-018-4182-3","volume":"37","author":"JG Royle","year":"2018","unstructured":"Royle JG, Lanyon PC, Grainge MJ, Abhishek A, Pearce FA (2018) The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink. Clin Rheumatol 37:2103\u20132111. https:\/\/doi.org\/10.1007\/s10067-018-4182-3","journal-title":"Clin Rheumatol"},{"key":"3267_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12931-019-0980-7","volume":"20","author":"V Cottin","year":"2019","unstructured":"Cottin V, Brown KK (2019) Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respiratory Res 20:13. https:\/\/doi.org\/10.1186\/s12931-019-0980-7","journal-title":"Respiratory Res"},{"key":"3267_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/BOR.0000000000000660","volume":"31","author":"DJ DeMizio","year":"2019","unstructured":"DeMizio DJ, Bernstein EJ (2019) Detection and classification of systemic sclerosis-related interstitial lung disease: a review. Curr Opin Rheumatol 31:553\u2013560. https:\/\/doi.org\/10.1097\/BOR.0000000000000660","journal-title":"Curr Opin Rheumatol"},{"key":"3267_CR5","first-page":"469","volume-title":"Pulmonary vascular disorders","author":"F Puppo","year":"2021","unstructured":"Puppo F, Negrini S, Carbone RG (2021) Pulmonary vascular injury in systemic sclerosis: diagnosis and treatment. In: Carbone RG, Puppo F, Tapson VF (eds) Pulmonary vascular disorders, 3rd edn. Nova Science Publishers, New York, pp 469\u2013484","edition":"3"},{"key":"3267_CR6","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737\u20132747. https:\/\/doi.org\/10.1002\/art.38098","journal-title":"Arthritis Rheum"},{"key":"3267_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","volume":"8","author":"A Perelas","year":"2020","unstructured":"Perelas A, Silver RM, Arrossi AV, Highland KB (2020) Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med 8:304\u2013320. https:\/\/doi.org\/10.1016\/S2213-2600(19)30480-1","journal-title":"Lancet Respir Med"},{"key":"3267_CR8","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/S2665-9913(19)30144-4","volume":"2","author":"AM Hoffmann-Vold","year":"2020","unstructured":"Hoffmann-Vold AM, Maher TM, Philpot EE et al (2020) The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. Lancet Rheumatol 2:e71-83. https:\/\/doi.org\/10.1016\/S2665-9913(19)30144-4","journal-title":"Lancet Rheumatol"},{"key":"3267_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10067-006-0302-6","volume":"26","author":"M Benan","year":"2007","unstructured":"Benan M, Hande I, Gul O (2007) The natural course of progressive systemic sclerosis patients with interstitial lung involvement. Clin Rheumatol 26:349\u2013354. https:\/\/doi.org\/10.1007\/s10067-006-0302-6","journal-title":"Clin Rheumatol"},{"key":"3267_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s10067-020-05296-w","volume":"26","author":"S Wangkaew","year":"2016","unstructured":"Wangkaew S, Euathrongchit J, Wattanawittawas P, Kasitanon N, Louthrenoo W (2016) Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: inception cohort study. Mod Rheumatol 26:588\u2013593. https:\/\/doi.org\/10.1007\/s10067-020-05296-w","journal-title":"Mod Rheumatol"},{"key":"3267_CR11","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JV Jr, Beebe-Dimmer J et al (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48:2246\u20132255. https:\/\/doi.org\/10.1002\/art.11073","journal-title":"Arthritis Rheum"},{"key":"3267_CR12","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1002\/art.21613","volume":"52","author":"V Steen","year":"2005","unstructured":"Steen V (2005) Advancements in diagnosis of pulmonary artery hypertension in scleroderma. Arthritis Rheum 52:3698\u20133700. https:\/\/doi.org\/10.1002\/art.21613","journal-title":"Arthritis Rheum"},{"key":"3267_CR13","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41431-018-0104-8","volume":"26","author":"CJW Stock","year":"2018","unstructured":"Stock CJW, Renzoni EA (2018) Genetic predictors of systemic sclerosis-associated interstitial lung disease: a review of recent literature. Eur J Hum Genet 26:765\u2013777. https:\/\/doi.org\/10.1038\/s41431-018-0104-8","journal-title":"Eur J Hum Genet"},{"key":"3267_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1164\/rccm.201903-0563CI","volume":"201","author":"D Khanna","year":"2020","unstructured":"Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, Varga J (2020) Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease. Am J Respir Crit Care Med 201:650\u2013660. https:\/\/doi.org\/10.1164\/rccm.201903-0563CI","journal-title":"Am J Respir Crit Care Med"},{"key":"3267_CR15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.5606\/ArchRheumatol.2018.6630","volume":"33","author":"E Jung","year":"2018","unstructured":"Jung E, Suh CH, Kim HA, Jung JY (2018) Clinical characteristics of systemic sclerosis with interstitial lung disease. Arch Rheumatol 33:322\u2013327. https:\/\/doi.org\/10.5606\/ArchRheumatol.2018.6630","journal-title":"Arch Rheumatol"},{"key":"3267_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/08916934.2017.1357699","volume":"50","author":"C Liaskos","year":"2017","unstructured":"Liaskos C, Marou E, Simopoulou T et al (2017) Disease-related autoantibody profile in patients with systemic sclerosis. Autoimmunity 50:414\u2013421. https:\/\/doi.org\/10.1080\/08916934.2017.1357699","journal-title":"Autoimmunity"},{"key":"3267_CR17","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1148\/radiol.2322031223","volume":"232","author":"SR Desai","year":"2004","unstructured":"Desai SR, Veeraraghavan S, Hansell DM et al (2004) CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 232:560\u2013567. https:\/\/doi.org\/10.1148\/radiol.2322031223","journal-title":"Radiology"},{"key":"3267_CR18","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1002\/art.39405","volume":"67","author":"YA Suliman","year":"2015","unstructured":"Suliman YA, Dobrota R, Huscher D et al (2015) Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol 67:3256\u20133261. https:\/\/doi.org\/10.1002\/art.39405","journal-title":"Arthritis Rheumatol"},{"key":"3267_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1378\/chest.13-2626","volume":"146","author":"TA Winstone","year":"2014","unstructured":"Winstone TA, Assayag D, Wilcox PG et al (2014) Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review. Chest 146:422\u2013436. https:\/\/doi.org\/10.1378\/chest.13-2626","journal-title":"Chest"},{"key":"3267_CR20","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s10067-018-4390-x","volume":"38","author":"FJ Garc\u00eda-Hern\u00e1ndez","year":"2019","unstructured":"Garc\u00eda-Hern\u00e1ndez FJ, Castillo-Palma MJ, Tolosa-Vilella C et al (2019) Pulmonary hypertension in Spanish patients with systemic sclerosis: data from the RESCLE registry. Clin Rheumatol 38:1117\u20131124. https:\/\/doi.org\/10.1007\/s10067-018-4390-x","journal-title":"Clin Rheumatol"},{"key":"3267_CR21","doi-asserted-by":"publisher","first-page":"e11437","DOI":"10.1097\/MD.0000000000011437","volume":"97","author":"K Niklas","year":"2018","unstructured":"Niklas K, Niklas A, Mularek-Kubzdela T, Puszczewicz M (2018) Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease. Medicine 97:e11437. https:\/\/doi.org\/10.1097\/MD.0000000000011437","journal-title":"Medicine"},{"key":"3267_CR22","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/art.40862","volume":"71","author":"A Young","year":"2019","unstructured":"Young A, Vummidi D, Visovatti S et al (2019) Prevalence, treatment, and outcomes of coexistent pulmonary hypertension and interstitial lung disease in systemic sclerosis. Arthritis Rheumatol 71:1339\u20131349. https:\/\/doi.org\/10.1002\/art.40862","journal-title":"Arthritis Rheumatol"},{"key":"3267_CR23","doi-asserted-by":"publisher","first-page":"1701197","DOI":"10.1183\/13993003.01197-2017","volume":"51","author":"JG Coghlan","year":"2018","unstructured":"Coghlan JG, Wolf M, Distler O et al (2018) Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis. Eur Respir J 51:1701197. https:\/\/doi.org\/10.1183\/13993003.01197-2017","journal-title":"Eur Respir J"},{"key":"3267_CR24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/diagnostics11050911","volume":"11","author":"M Naranjo","year":"2021","unstructured":"Naranjo M, Hassoun PM (2021) Systemic sclerosis-associated pulmonary hypertension: spectrum and impact. Diagnostics 11:911. https:\/\/doi.org\/10.3390\/diagnostics11050911","journal-title":"Diagnostics"},{"key":"3267_CR25","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.3899\/jrheum.101243","volume":"8","author":"M Hinchcliff","year":"2011","unstructured":"Hinchcliff M, Fischer A, Schiopu E, Steen VD (2011) Pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS): baseline characteristics and description of study population. J Rheumatol 8:2172\u20132179. https:\/\/doi.org\/10.3899\/jrheum.101243","journal-title":"J Rheumatol"},{"key":"3267_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ijcard.2016.03.084","volume":"212","author":"E Vandecasteele","year":"2016","unstructured":"Vandecasteele E, De Pauw M, De Keyser F et al (2016) Six-minute walk test in systemic sclerosis: a systematic review and meta-analysis. Int J Cardiol 212:265\u2013273. https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.084","journal-title":"Int J Cardiol"},{"key":"3267_CR27","doi-asserted-by":"publisher","first-page":"e0181692","DOI":"10.1371\/journal.pone.0181692","volume":"12","author":"N Le Gouellec","year":"2017","unstructured":"Le Gouellec N, Duhamel A, Perez T et al (2017) Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease. PLoS ONE 12:e0181692. https:\/\/doi.org\/10.1371\/journal.pone.0181692","journal-title":"PLoS ONE"},{"key":"3267_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/art.24267","volume":"60","author":"SC Mathai","year":"2009","unstructured":"Mathai SC, Hummers LK, Champion HC et al (2009) Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum 60:569\u2013577. https:\/\/doi.org\/10.1002\/art.24267","journal-title":"Arthritis Rheum"},{"key":"3267_CR29","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1038\/s41598-022-09353-z","volume":"2","author":"AG Del-Castillo","year":"2022","unstructured":"Del-Castillo AG, Meseguer ML, Fonollosa-Pla V et al (2022) Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary artery hypertension. Sci Rep 2:5289. https:\/\/doi.org\/10.1038\/s41598-022-09353-z","journal-title":"Sci Rep"},{"key":"3267_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10067-016-3504-6","volume":"36","author":"M Michelfelder","year":"2017","unstructured":"Michelfelder M, Becker M, Riedlinger A et al (2017) Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary artery hypertension without affecting hemodynamics and exercise capacity. Clin Rheumatol 36:381\u2013390. https:\/\/doi.org\/10.1007\/s10067-016-3504-6","journal-title":"Clin Rheumatol"},{"key":"3267_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/art.21538","volume":"54","author":"S Trad","year":"2006","unstructured":"Trad S, Amoura Z, Beigelman C et al (2006) Pulmonary artery hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum 54:184\u2013191. https:\/\/doi.org\/10.1002\/art.21538","journal-title":"Arthritis Rheum"},{"key":"3267_CR32","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1002\/art.30423","volume":"63","author":"J Le Pavec","year":"2011","unstructured":"Le Pavec J, Girgis RE, Lechtzin N et al (2011) Systemic sclerosis\u2013related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. Arthritis Rheum 63:2456\u20132464. https:\/\/doi.org\/10.1002\/art.30423","journal-title":"Arthritis Rheum"},{"key":"3267_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-60327-074-8_8","volume-title":"Pulmonary arterial hypertension and interstitial lung diseases","author":"AN Brown","year":"2009","unstructured":"Brown AN, Strange C (2009) Connective tissue disease and vasculitis-associated interstitial lung disease. In: Baughman RP, Carbone RG, Bottino G (eds) Pulmonary arterial hypertension and interstitial lung diseases, 12th edn. Humana Press, New York, pp 159\u2013175","edition":"12"},{"key":"3267_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.semarthrit.2014.03.002","volume":"44","author":"VM Hsu","year":"2014","unstructured":"Hsu VM, Chung L, Hummers LK et al (2014) Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. Semin Arthr Rheum 44:55\u201362. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.03.002","journal-title":"Semin Arthr Rheum"},{"issue":"Suppl 86","key":"3267_CR35","first-page":"S109","volume":"32","author":"A Fischer","year":"2014","unstructured":"Fischer A, Swigris J, Bolster MB et al (2014) Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters. Clin Exp Rheumatol 32(Suppl 86):S109\u2013S114","journal-title":"Clin Exp Rheumatol"},{"key":"3267_CR36","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1378\/chest.10-2473","volume":"140","author":"D Launay","year":"2011","unstructured":"Launay D, Humbert M, Berezne A et al (2011) Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. Chest 140:1016\u20131024. https:\/\/doi.org\/10.1378\/chest.10-2473","journal-title":"Chest"},{"key":"3267_CR37","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL et al (2018) Diagnosis of idiopathic pulmonary fibrosis: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 198:e44\u2013e68. https:\/\/doi.org\/10.1164\/rccm.201807-1255ST","journal-title":"Am J Respir Crit Care Med"},{"key":"3267_CR38","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L et al (2022) Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults an official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 205:e18\u2013e47. https:\/\/doi.org\/10.1164\/rccm.202202-0399ST","journal-title":"Am J Respir Crit Care Med"},{"key":"3267_CR39","doi-asserted-by":"publisher","first-page":"2200425","DOI":"10.1183\/13993003.00425-2022","volume":"60","author":"DA Korevaar","year":"2022","unstructured":"Korevaar DA, Colella S, Fally M et al (2022) European Respiratory Society guidelines on transbronchial lung cryobiopsy in the diagnosis of interstitial lung diseases. Eur Respir J 60:2200425. https:\/\/doi.org\/10.1183\/13993003.00425-2022","journal-title":"Eur Respir J"},{"key":"3267_CR40","doi-asserted-by":"publisher","first-page":"1901144","DOI":"10.1183\/13993003.01144-2019","volume":"54","author":"V Tzilas","year":"2019","unstructured":"Tzilas V, Tzouvelekis A, Bouros E et al (2019) Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging pattern. Eur Resp J 54:1901144. https:\/\/doi.org\/10.1183\/13993003.01144-2019","journal-title":"Eur Resp J"},{"key":"3267_CR41","doi-asserted-by":"publisher","first-page":"170102","DOI":"10.1183\/16000617.0102-2017","volume":"27","author":"M Caron","year":"2018","unstructured":"Caron M, Hoa S, Hudson M, Schwartzman K, Steele R (2018) Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease. Eur Respir Rev 27:170102. https:\/\/doi.org\/10.1183\/16000617.0102-2017","journal-title":"Eur Respir Rev"},{"key":"3267_CR42","doi-asserted-by":"publisher","first-page":"1600016","DOI":"10.1183\/13993003.00016-2016","volume":"49","author":"BL Graham","year":"2016","unstructured":"Graham BL, Brusasco V, Burgos F et al (2016) 2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J 49:1600016. https:\/\/doi.org\/10.1183\/13993003.00016-2016","journal-title":"Eur Respir J"},{"key":"3267_CR43","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1164\/rccm.201710-1981ST","volume":"196","author":"BH Culver","year":"2017","unstructured":"Culver BH, Graham BL, Coates AL et al (2017) Recommendations for a standardized pulmonary function report an official American Thoracic Society Technical Statement. Am J Respir Crit Care Med 196:1463\u20131472. https:\/\/doi.org\/10.1164\/rccm.201710-1981ST","journal-title":"Am J Respir Crit Care Med"},{"key":"3267_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijcha.2016.05.011","volume":"12","author":"S Parasuraman","year":"2016","unstructured":"Parasuraman S, Walker S, Loudon BL et al (2016) Assessment of pulmonary artery pressure by echocardiography\u2014a comprehensive review. Int J Cardiol Heart Vasc 12:45\u201351. https:\/\/doi.org\/10.1016\/j.ijcha.2016.05.011","journal-title":"Int J Cardiol Heart Vasc"},{"key":"3267_CR45","doi-asserted-by":"publisher","first-page":"G11","DOI":"10.1530\/ERP-17-0071","volume":"5","author":"DX Augustine","year":"2018","unstructured":"Augustine DX, Coates-Bradshaw LD, Willis J et al (2018) Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography. Echo Res Pract 5:G11\u2013G24. https:\/\/doi.org\/10.1530\/ERP-17-0071","journal-title":"Echo Res Pract"},{"issue":"Suppl V","key":"3267_CR46","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1136\/thx.2008.101691","volume":"63","author":"AU Wells","year":"2008","unstructured":"Wells AU, Hirani N, on behalf of the British Thoracic Society Interstitial Lung Disease Guideline Group, a subgroup of the British Thoracic Society Standards of Care Committee, in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society (2008) Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 63(Suppl V):v1\u2013v58. https:\/\/doi.org\/10.1136\/thx.2008.101691","journal-title":"Thorax"},{"key":"3267_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Galie","year":"2016","unstructured":"Galie N, Humbert M, Vachiery JL et al (2016) 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67\u2013119. https:\/\/doi.org\/10.1093\/eurheartj\/ehv317","journal-title":"Eur Heart J"},{"key":"3267_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/IBPC.S232038","volume":"13","author":"S Almaaitah","year":"2020","unstructured":"Almaaitah S, Highland KB, Tonelli AR (2020) Management of pulmonary artery hypertension in patients with systemic sclerosis. Integr Blood Press Control 13:15\u201329. https:\/\/doi.org\/10.2147\/IBPC.S232038","journal-title":"Integr Blood Press Control"},{"key":"3267_CR49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1378\/chest.132.4","volume":"132","author":"RG Carbone","year":"2007","unstructured":"Carbone RG, Privitera V, Montanaro F, Monselise A, Ghio R (2007) Emerging indicators of survival in cellular and fibrotic nonspecific interstitial pneumonia. Chest 132:457. https:\/\/doi.org\/10.1378\/chest.132.4","journal-title":"Chest"},{"key":"3267_CR50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/acr2.11398","volume":"4","author":"B Jandali","year":"2022","unstructured":"Jandali B, Salazar GA, Hudson M et al (2022) The effect of anti-Scl-70 antibody determination method on its predictive significance for interstitial lung disease progression in systemic sclerosis. ACR Open Rheumatol 4:345\u2013351. https:\/\/doi.org\/10.1002\/acr2.11398","journal-title":"ACR Open Rheumatol"},{"key":"3267_CR51","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM et al (2022) 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43:3618\u20133731. https:\/\/doi.org\/10.1093\/eurheartj\/ehac237","journal-title":"Eur Heart J"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-023-03267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-023-03267-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-023-03267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T19:19:59Z","timestamp":1688671199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-023-03267-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3267"],"URL":"https:\/\/doi.org\/10.1007\/s11739-023-03267-y","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"22 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was not required as the study is retrospecitve.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement and Informed consent"}}]}}